These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15826264)

  • 1. Cardiac resynchronization induces favorable neurohumoral changes.
    Erol-Yilmaz A; Verberne HJ; Schrama TA; Hrudova J; De Winter RJ; Van Eck-Smit BL; De Bruin R; Bax JJ; Schalij MJ; Wilde AA; Tukkie R
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):304-10. PubMed ID: 15826264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
    Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
    Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and echocardiographic correlates of improvement in left ventricular diastolic function after cardiac resynchronization therapy.
    Aksoy H; Okutucu S; Kaya EB; Deveci OS; Evranos B; Aytemir K; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Europace; 2010 Sep; 12(9):1256-61. PubMed ID: 20478931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy.
    Soliman OI; Theuns DA; Geleijnse ML; Anwar AM; Nemes A; Caliskan K; Vletter WB; Jordaens LJ; Cate FJ
    Europace; 2007 Feb; 9(2):113-8. PubMed ID: 17218390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of cardiac resynchronization therapy on arterial distensibility and serum norepinephrine levels in advanced heart failure.
    Yildiz M; Hasdemir H; Turkkan C; Astarcioglu MA; Alper AT; Sahin A; Ozkan M
    Cardiol J; 2013; 20(3):304-9. PubMed ID: 23788305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography.
    Penicka M; Bartunek J; De Bruyne B; Vanderheyden M; Goethals M; De Zutter M; Brugada P; Geelen P
    Circulation; 2004 Mar; 109(8):978-83. PubMed ID: 14769701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
    St John Sutton MG; Plappert T; Abraham WT; Smith AL; DeLurgio DB; Leon AR; Loh E; Kocovic DZ; Fisher WG; Ellestad M; Messenger J; Kruger K; Hilpisch KE; Hill MR;
    Circulation; 2003 Apr; 107(15):1985-90. PubMed ID: 12668512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy.
    Pitzalis MV; Iacoviello M; Di Serio F; Romito R; Guida P; De Tommasi E; Luzzi G; Anaclerio M; Varraso L; Forleo C; Pansini N
    Eur J Heart Fail; 2006 Aug; 8(5):509-14. PubMed ID: 16503416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Geleijnse ML; Theuns DA; Nemes A; Vletter WB; van Dalen BM; Motawea AK; Jordaens LJ; ten Cate FJ
    Am J Cardiol; 2008 Mar; 101(5):651-7. PubMed ID: 18308015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
    Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography.
    Yu CM; Chan YS; Zhang Q; Yip GW; Chan CK; Kum LC; Wu L; Lee AP; Lam YY; Fung JW
    J Am Coll Cardiol; 2006 Dec; 48(11):2251-7. PubMed ID: 17161255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices.
    Horwich T; Foster E; De Marco T; Tseng Z; Saxon L
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1284-9. PubMed ID: 15574179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure.
    Yu CM; Fung JW; Chan CK; Chan YS; Zhang Q; Lin H; Yip GW; Kum LC; Kong SL; Zhang Y; Sanderson JE
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1058-65. PubMed ID: 15363081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Heart; 2006 May; 92(5):625-30. PubMed ID: 16159967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
    Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy.
    Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M
    J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy.
    Hardt SE; Yazdi SH; Bauer A; Filusch A; Korosoglou G; Hansen A; Bekeredjian R; Ehlermann P; Remppis A; Katus HA; Kuecherer HF
    Int J Cardiol; 2007 Feb; 115(3):318-25. PubMed ID: 16891011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes after cardiac resynchronization therapy: importance of left ventricular diastolic function and origin of heart failure.
    Waggoner AD; Rovner A; de las Fuentes L; Faddis MN; Gleva MJ; Sawhney N; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Mar; 19(3):307-13. PubMed ID: 16500494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.